Clinical trial
Ultra-wide Fluorescein angiograpHy to Evaluate the Progression of Retinal ischeMia After aflibErcept Injections in patientS With Central Retinal Vein Occlusion in Real Life (HERMES Study)
NCT02880644 is registered in ClinicalTrials.gov with Centre Hospitalier Intercommunal Creteil as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ultra-wide Fluorescein angiograpHy to Evaluate the Progression of Retinal ischeMia After aflibErcept Injections in patientS With Central Retinal Vein Occlusion in Real Life (HERMES Study)
- Lead sponsor
- Centre Hospitalier Intercommunal Creteil
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 26, 2017
- Completion date
- November 30, 2022
- Enrollment
- 65 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.